STOAF III SciTech invests in sustainable water cleaning company Stockholm Water Technology

STOAF III SciTech, Almi Invest and SEA (Sustainable Energy Angels) are investing a total of SEK 10 million in Stockholm Water Technology, which offers smart, clean, and sustainable water purification solutions primarily for industrial use. The money will go towards market introduction and product development.

Around 2.2 billion people are currently estimated to lack access to a necessary amount of clean drinking water. This means that the demand for circular and sustainable water treatment methods is increasing as resources decrease and requirements are increased through laws and regulations.
After many years of research, Stockholm Water Technology (SWT) has developed a water purification solution that enables sustainable, affordable, and efficient water management. The patented solution requires lower energy compared to existing alternatives because it is independent of water temperature, has high water recovery and does not have membranes, which requires more energy.

The company has developed a strong and patented technology in a rapidly growing area, says Marcus Boijemyr, Fund Manager at Almi Invest. SWT addresses a large and growing market where their technical solution is cheaper, energy efficient and more scalable compared to today’s solutions.

SWT’s unique ability to use a single technology, purifying water from many different contaminants, will have a groundbreaking impact in many applications where a combination of several different systems is required today, says Magnus Eriksson, General Partner at STOAF III SciTech. SWT fits well into our investment strategy, which focuses on companies with complex, advanced technology, global market and contributes to a sustainable world.

SWT has a uniquely effective and energy-efficient solution in water purification, one of the most important areas for a future sustainable world, says Olof Heyman, Investment Manager at SEA. Through its combination of AI and technical solution, it has created a highly competitive product.

SWT is in various stages of testing and sales with some fifteen customers and has already sold some units. The company is now facing market introduction, where the focus will be primarily on water treatment in the industrial sector and in the real estate sector, primarily municipalities.

”We are very excited about this investment,” said Dr Karthik Laxman Kunjali,CEO and founder of Stockholm Water Technology. Now we can invest in expansion and seriously introduce our product, which is suitable for many different application areas and has better potential to work on a larger scale than existing solutions.

For further information contact
Karthik Laxman Kunjali, CEO Stockholm Water Technology, email:
Magnus Eriksson, General Partner, STOAF III SciTech, phone +46 (0)733 40 04 64, email:

STOAF III SciTech invests in Aligned Bio

februari 4th, 2021|

Aligned Bio, a single molecule detection company, announced an oversubscribed A round investment of 23 MSEK led by STOAF III SciTech and Fårö Capital. Previous investors Almi Invest and MIST Ventures continued their participation.

STOAF III SciTech invests in Stroke Alarm company Uman Sense

oktober 21st, 2020|

In an oversubscribed new share issue, the medtech company Uman Sense has raised SEK 6.3 million. Among the new co-owners are STOAF III SciTech, Gobia Enterprises, and Queen Invest. Uman Sense has developed and CE-marked the medical device Stroke Alarm, a medical device which is now being tested in a clinical trial on patients at a high risk for stroke.

STOAF III SciTech invests in Developeration’s innovative surgical device

september 15th, 2020|

STOAF III SciTech och Almi Invest each invests 1.9 MSEK in Developeration AB, who has developed an innovative surgical instrument for treatment of hemmorhoids. The emission of 4.4 MSEK will be used for further product development and clinical trials. Hemorrhoids affect about 25 percent of the population over the age of 50 in the Western world. There are currently several different ways to treat hemorrhoids, but they carry a high risk of recurrence or complications, are expensive, take a long time, require access to the operating theater, are painful, or a combination of these.


juni 8th, 2020|

STOAF II PORTFOLIO COMPANY ILYA PHARMA AWARDED €5.3M FROM EIC ACCELERATOR TO FAST TRACK PHASE II STUDY OF FIRST-IN-CLASS ILP100 ADVANCE THERAPY FOR WOUND TREATMENT IN PEOPLE WITH DIABETES Ilya Pharma, a clinical stage biopharma company developing novel chemokine gene therapies with its ILP-technology platform, today announced that it has secured a total of Euros 5.3 million in funding from the European Innovation Council (EIC) Accelerator program of blended financing.